Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
QPRT Drives Breast Cancer Invasiveness via Rho/ROCK-Myosin P
2026-04-27
Liu et al. (2021) demonstrate that quinolinate phosphoribosyltransferase (QPRT) enhances breast cancer cell invasiveness by promoting myosin light chain phosphorylation through the Rho/ROCK signaling cascade. Their mechanistic findings suggest QPRT as a potential prognostic marker and therapeutic target in aggressive breast cancer.
-
Canagliflozin Remodels Mitochondria in Diabetic Mouse Kidney
2026-04-27
This study reveals that canagliflozin, a selective SGLT2 inhibitor, not only lowers glucose but also remodels mitochondrial structure and improves bioenergetic function in proximal tubular cells of hypertensive–diabetic mice. These findings provide mechanistic insight into renal protective effects, expanding the therapeutic relevance of SGLT2 inhibitors in kidney disease research.
-
Protease Inhibitor Cocktail EDTA-Free (100X in DMSO): Techni
2026-04-26
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) addresses proteolytic degradation during protein extraction and sample preparation, particularly where preservation of divalent cations is necessary. It is suitable for workflows such as Western blotting, co-immunoprecipitation, and phosphorylation analysis. This product should not be used when EDTA-mediated metalloprotease inhibition is required.
-
Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Techn
2026-04-25
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) prevents protein degradation during extraction and sample prep, especially in workflows sensitive to divalent cations. It is not suitable for protocols requiring metalloprotease inhibition by chelation. For optimal results, integrate this cocktail into workflows such as Western blotting, co-immunoprecipitation, and kinase assays.
-
LGK-974: Precision PORCN Inhibitor for Wnt Pathway Research
2026-04-24
LGK-974 empowers researchers to dissect and modulate Wnt signaling with nanomolar precision, offering robust tumor suppression in Wnt-dependent models while maintaining high cell viability. This article details actionable workflows, troubleshooting strategies, and direct assay enhancements that set LGK-974 apart as a benchmark PORCN inhibitor for translational oncology and developmental biology.
-
Neuroinflammation and Piezo2 Signaling in Trigeminal Allodyn
2026-04-24
Liao et al. uncover how neuroinflammatory responses from trigeminal nerve root compression drive mechanical allodynia through a Ca2+-dependent CGRP/SP-Piezo2 axis. Their integrative in vivo and in vitro analyses delineate a feedback loop between neuropeptide signaling and mechanotransduction, providing a new mechanistic framework for trigeminal neuralgia pathogenesis.
-
Brefeldin A: Translational Leverage in ER Stress and Cancer
2026-04-23
This thought-leadership article explores the mechanistic depth and translational potential of Brefeldin A (BFA) as a vesicle transport inhibitor, ER stress inducer, and apoptosis modulator in cancer and endothelial injury models. Integrating recent evidence and protocol intelligence, it provides actionable guidance for researchers seeking robust, reproducible results. By bridging bench insights with strategic vision, this piece uniquely positions BFA from APExBIO as more than a reagent—it's a catalyst for discovery.
-
ACSL4-Driven Fatty Acid β-Oxidation Governs Endometrial Deci
2026-04-23
This study reveals that long-chain acyl-CoA synthetase-4 (ACSL4) is essential for endometrial decidualization by promoting fatty acid β-oxidation, rather than by increasing lipid droplet accumulation. The findings clarify a key metabolic pathway underlying successful implantation, offering new perspectives for reproductive biology and translational research.
-
Mubritinib (TAK 165): Targeting Complex I in Cancer Research
2026-04-22
Mubritinib (TAK 165) uniquely inhibits mitochondrial complex I, offering selective cytotoxicity for chemotherapy-resistant AML and KSHV-driven lymphomas. This guide translates cutting-edge findings into actionable workflows, troubleshooting tips, and comparative insights, empowering advanced cancer and virology research.
-
EGTA (Egtazic Acid): Precision Calcium Chelation in Research
2026-04-22
EGTA, an aminopolycarboxylic acid known as egtazic acid, acts as a selective calcium chelator with high affinity. It is widely used for modulating calcium signaling pathways and protecting cells from calcium-mediated cytotoxicity. High-purity EGTA from APExBIO (SKU B7195) is validated for research applications including neuroprotection and apoptosis assays.
-
Brefeldin A in Cancer Cell Biology: Protocols, ER Stress, an
2026-04-21
Brefeldin A (BFA) is a powerful tool for dissecting ER stress and apoptosis in cancer research, with unique advantages in tracking protein trafficking and vesicle dynamics. This article delivers evidence-backed workflow enhancements, troubleshooting tips, and insights from recent advances in ER protein quality control, all anchored by APExBIO’s high-purity BFA.
-
CHIR-99021 (CT99021): Optimizing Stem Cell and Neuroimmune W
2026-04-21
CHIR-99021 (CT99021) is a benchmark GSK-3 inhibitor, driving robust pluripotency maintenance, directed differentiation, and advanced neuroimmune modeling. This guide delivers actionable protocols and troubleshooting insights for maximizing reliability and performance with APExBIO’s CHIR-99021 across stem cell, neuronal, and TGF-β/Nodal signaling research.
-
Protease Inhibitor Cocktail EDTA-Free: Workflow Enhancements
2026-04-20
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO enables superior protein preservation in workflows sensitive to proteolysis and divalent cations. Its robust, EDTA-free formulation unlocks advanced applications in phosphorylation analysis, immunoprecipitation, and lysosomal repair studies—empowering reproducibility even under extreme cellular stress.
-
Norovirus Exploits NINJ1 for Selective Viral Protein Secreti
2026-04-20
This study uncovers how murine norovirus (MNoV) hijacks the host membrane rupture factor NINJ1 to selectively secrete its NS1 protein, revealing a previously unknown mechanism for viral protein export during apoptosis. The work provides key insights into regulated plasma membrane rupture and its implications for both viral pathogenesis and programmed cell death.
-
Biotin-16-UTP: Applied RNA Labeling for Detection & Purifica
2026-04-19
Biotin-16-UTP empowers sensitive and reproducible RNA detection, purification, and interaction studies through robust biotin-streptavidin binding. Discover optimized experimental workflows, troubleshooting strategies, and advanced applications that leverage APExBIO’s validated biotin-labeled uridine triphosphate for high-impact molecular biology research.